NCT01832051View on ClinicalTrials.gov

Clinical Value of 89Zr-trastuzumab PET

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

October 31, 2015

Conditions
Metastatic Breast Cancer
Interventions
DRUG

89Zr-trastuzumab injection

Trial Locations (1)

Unknown

University Medical Center, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01832051 - Clinical Value of 89Zr-trastuzumab PET | Biotech Hunter | Biotech Hunter